Clinical Trial Update: Assessment of Cod Protein as an Insulin-sensitizing Agent in Women With Polycystic Ovary Syndrome. [NA]

View source ↗

Summary

A clinical trial evaluating cod protein as an insulin-sensitizing agent in women with polycystic ovary syndrome has completed. The sponsor was Laval University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Cod Protein

Snippet

Sponsor: Laval University | Conditions: Insulin Sensitivity, Polycystic Ovarian Syndrome | NA | Status: COMPLETED